In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
- TRADE NAME: Apidra (Sanofi-Aventis)
- INDICATIONS: Diabetes
- CLASS: Insulin analog
- HALF-LIFE: 13–42 minutes
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Albuterol, Alcohol, Anitpsychotics, Beta blockers, Clonidine, Clozapine, Corticosteroids, Danazol, Disopyramide, Diuretics, Epinephrine, Fibrates, Fluoxetine, Glucagon, Guanethidine, Isoniazid, Lithium, MAO inhibitors, Niacin, Oral antidiabetic agents, Oral Contraceptives, Pentamidine, Pentoxifylline, Phenothiazine derivatives, Pramlintide, Propoxyphene, Propranolol, Protease inhibitors, Reserpine, Salicylates, Somatostatin analogs, Somatropin, Sulfonamide antibiotics, Terbutaline, Thyroid hormones
Various forms of insulin are available - see other insulin profiles for reaction details.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
